[1]刘凯娟,李维康,王力普,等.李佃贵从“五脏”论治难治性反流性食管炎经验*[J].陕西中医,2020,(8):1144.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
　LIU Kaijuan,LI Weikang,WANG Lipu,et al.Traditional Chinese medicine master Li Diangui's experience in treating refractory reflux esophagitis from “five organs”[J].,2020,(8):1144.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
点击复制

李佃贵从“五脏”论治难治性反流性食管炎经验*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年8期
页码:
1144
栏目:
名老中医经验
出版日期:
2020-08-05

文章信息/Info

Title:
Traditional Chinese medicine master Li Diangui's experience in treating refractory reflux esophagitis from “five organs”
作者:
刘凯娟1; 李维康1; 王力普1; 白海燕2△; 郝旭蕊1; 李 娜1; 翟付平1
1.河北中医学院研究生院(石家庄050091); 2.河北中医学院附属医院(石家庄050011)
Author(s):
LIU Kaijuan; LI Weikang; WANG Lipu; et al.
Graduate School of Hebei College of Traditional Chinese Medicine(Shijiazhuang 050091)
关键词:
难治性反流性食管炎;  调治五脏;  和胃降逆;  名医经验;  李佃贵
Keywords:
Refractory reflux esophagitis;  Treating the five internal organs;  Hewei Jiangni;  Experience of famous doctor;  Li Diangui
分类号:
R571
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.035
文献标志码:
A
摘要:
难治性反流性食管炎是一种消化系统的难治病、常见病。李佃贵教授将其从“五脏”治疗难治性反流性食管炎,认为该病的病位虽在食道,属胃所主,但其发病与五脏密切相关。脾失健运、升降失衡,肝郁不舒、克伐胃土,心失所养、络郁不通,肺失宣降、胃失和降,肾水亏虚、胃阴失滋,均可累及胃腑,致其通降失职,气机不利,郁而化火,参与难治性反流性食管炎的发生发展及其传变。故临证时,李教授在和胃降逆的基础上予以“升脾阳、运脾气”“疏肝、凉肝”“温心阳、清心火”“宣肺、肃肺”“滋肾阴”等治法,调治五脏,使五脏功能正常运转,病情得到有效控制。
Abstract:
Refractory reflux esophagitis is a refractory and common disease of the digestive system.The author is fortunate to follow Professor Li Diangui's clinical study,and now he uses his experience in treating refractory reflux esophagitis from the “five organs” to readers.Professor Li believes that although the disease is located in the esophagus and belongs to the stomach,its incidence is closely related to the five internal organs.Spleen loss of health,unbalanced movements,liver depression,unsatisfactory liver,keval stomach,heart failure,nourishment of collateral depression,loss of lung loss,stomach loss and drop,kidney water deficiency,stomach yin loss,can all affect the stomach Fu,causing its failure to pass the job,unfavorable vitality,stagnation and fire,participated in the development and transmission of refractory reflux esophagitis.Therefore,on the basis of the approval of the stomach,Professor Li gave “lifting spleen yang,transporting spleen qi”,“spleen liver,cooling liver”,“warming heart yang,clearing heart fire”,“Xuanfei,sufei”,“zishenyin”,etc.Governing law,regulating the five internal organs,making the five internal organs function normally,and the disease condition is effectively controlled.

参考文献/References:

[1] 王 健,林柳兵,沈 莹,等.疏肝和中汤联合雷贝拉唑治疗肝胃郁热型反流性食管炎临床研究[J].陕西中医,2020,41(2):168-171.
[2] 叶少情,蔡 丽,邱承智,等.反流性食管炎中医治疗研究进展[J].湖南中医杂志,2019,35(4):165-167.
[3] 徐 阳,唐艳萍.难治性反流性食管炎的病因及诊治研究进展[J].中国中西医结合外科杂志,2020,26(1):183-186.
[4] 李芳芳,黄巨霞.雷贝拉唑联合莫沙必利对反流性食管炎患者幽门螺杆菌感染及炎症因子水平影响研究[J].陕西医学杂志,2019,48(10):1378-1380.
[5] 杨少军,陈 玲,利 霞,等.疏肝和胃方治疗胃食管反流病70例临床研究[J].时珍国医国药,2019,30(7):1668-1670.
[6] 赵润元,刘小发.李佃贵国医大师从浊毒论治脾胃病临床体悟[J].世界中西医结合杂志,2018,13(3):335-337,373.
[7] 李 佳.从气神同调法论治胃食管反流病相关性咽异感症[J].中医学报,2020,35(4):765-768.
[8] 张冰冰,朱爱松,石 岩.对于“五脏相关”理论的科学内涵探讨[J].中华中医药杂志,2017,32(7):3259-3263.
[9] 张馨月,姜小艳,刘冬厚,等.舒郁消瘅汤联合西药治疗难治性反流性食管炎合并焦虑抑郁状态疗效观察[J].现代中西医结合杂志,2019,28(10):1036-1040,1075.
[10] 张嘉琰,张立平.张立平教授治疗反流性食管炎经验[J].西部中医药,2019,32(7):54-57.
[11] 李 慧.张锡纯阐发中医藏象理论发微[J].浙江中医药大学学报,2019,43(11):1230-1232.
[12] 刘枫凤.叶天士足阳明胃经辨证方法研究[D].北京:北京中医药大学,2018.
[13] 杨 丽.基于古代文献脾主运化、统血理论的发展源流及从脾论治相关疾病的研究[D].沈阳:辽宁中医药大学,2018.
[14] 王红梅,张立平,陈丽如,等.基于胃食管反流病的胃肠动力与脾虚实质探究[J].中国中西医结合消化杂志,2015,23(3):196-198.
[15] 袁旭潮,王捷虹,王康永,等.《临证指南医案》从肝论治胃痛医案的证治分析[J].江苏中医药,2016,48(8):9-10.
[16] 李 娟.芪石升降归元丸治疗中虚气逆型胃食管反流病的临床疗效观察[D].南宁:广西中医药大学,2019.
[17] 张薇薇.“通法”思想在脾胃病中的应用研究[D].成都:成都中医药大学,2018.
[18] 黄帝内经素问[M].北京:人民卫生出版社,2005:49.
[19] 张 倩.《黄帝内经》经脉脏腑相关理论研究[D].合肥:安徽中医药大学,2019.
[20] 陈永灿.左金丸临证思考[J].江苏中医药,2015,47(11):63-64.
[21] 叶长平,商洪涛.关于单味中药枇杷叶研究的思考[J].中医临床研究,2018,10(16):8-10.

相似文献/References:

[1]王力普,翟付平,马 伟,等.蒲苓连夏方治疗难治性反流性食管炎临床观察[J].陕西中医,2021,(11):1557.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.014]
　WANG Lipu,ZHAI Fuping,MA Wei,et al.Clinical observation of Puling Lianxia decoction in the treatment of refractory reflux esophagitis[J].,2021,(8):1557.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.014]

备注/Memo

备注/Memo:
*河北省中医药管理局科研项目(2019017)
更新日期/Last Update: 2020-08-10